TL
Telix Pharmaceuticals Limited (TLX)
NASDAQ·Healthcare·Biotechnology
$10.11
-0.79%
Mkt Cap $2.54B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$19.00
Range $17.00 – $20.00
Implied Upside
+87.9%
Consensus $19.00 vs current $10.11
NASDAQ·Healthcare·Biotechnology
$10.11
-0.79%
Mkt Cap $2.54B
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$19.00
Range $17.00 – $20.00
+87.9%
Consensus $19.00 vs current $10.11